2022-04-25T12:47:58-05:00 2021-06-30 861065772 DELOITTE TAX LLP 1033 DEMONBREUN STREET SUITE 400 NASHVILLE TN 37203 990 2020-07-01 351044585 AMERICAN LEBANESE SYRIAN ASSOCIATED CHARITIES INC AMER 9015782000 501 ST JUDE PLACE MEMPHIS TN 38105 KERA WRIGHT CHIEF FINANCIAL OFFICER 9015782000 2022-04-22 1 KERA WRIGHT 999009999 FRANCIS J BEDARD P00752421 6152591800 2 AAL1 IAL1 2020 2022-09-23 18:48:47Z RICHARD C SHADYAC JR 501 ST JUDE PLACE MEMPHIS TN 38105 3334378002 0 X WWW.STJUDE.ORG X 1957 IL TO RAISE FUNDS AND BUILD AWARENESS TO SUSTAIN THE MISSION OF ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. 41 38 1939 1000000 -2634893 0 1744366291 2024430417 0 0 122400176 340940644 31522855 38331043 1898289322 2403702104 974742522 997103326 0 0 189800903 181743089 9409576 11304762 289183184 390400394 432893536 1564353395 1623044713 333935927 780657391 5848337695 8164081055 111924730 124613358 5736412965 8039467697 X AMERICAN LEBANESE SYRIAN ASSOCIATED CHARITIES, INC. (ALSAC) WAS FOUNDED IN 1957 AND EXISTS SOLELY TO RAISE FUNDS AND BUILD AWARENESS TO SUSTAIN THE MISSION OF ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. TO ADVANCE CURES, AND MEANS OF PREVENTION, FOR PEDIATRIC CATASTROPHIC DISEASES THROUGH RESEARCH AND TREATMENT WHILE HONORING THE MEMORY AND HERITAGE OF OUR FOUNDER, DANNY THOMAS. 0 0 1173124673 997103326 28854217 ALSAC IS THE FUNDRAISING AND AWARENESS ORGANIZATION FOR ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. (ST. JUDE). ALSAC EXISTS SOLELY TO RAISE FUNDS AND BUILD AWARENESS TO SUSTAIN THE MISSION OF ST. JUDE CHILDREN'S RESEARCH HOSPITAL TO ADVANCE CURES, AND MEANS OF PREVENTION, FOR PEDIATRIC CATASTROPHIC DISEASES THROUGH RESEARCH AND TREATMENT WHILE HONORING THE MEMORY AND HERITAGE OF OUR FOUNDER, DANNY THOMAS. THANKS TO GENEROUS DONORS, FAMILIES NEVER RECEIVE A BILL FROM ST. JUDE FOR TREATMENT, TRAVEL, HOUSING OR FOOD - SO THEY CAN FOCUS ON HELPING THEIR CHILD LIVE. (CONTINUED ON SCHEDULE O) 1173124673 1 0 0 0 0 0 0 0 0 1 1 1 0 0 1 1 1 1 0 0 1 0 0 1 1 1 0 1 0 1 0 0 0 0 0 0 1 0 1 1 0 0 0 1 0 0 0 1 X 790 81 1 1939 1 1 1 1 AS BD BR VI CA CJ CH DA FR GM GK HK IN EI IT JA MP MX NL SP SW SZ TW UK 0 0 0 1 1 0 0 0 1 0 0 0 X 41 38 1 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 AL CA CT FL GA HI IL KS KY MA MD MI MN MS NH NJ NM NY OH OK OR PA RI SC TN UT WA WI WV X X X KERA WRIGHT 9015782150 501 ST JUDE PLACE MEMPHIS TN 38105 JAMES R DOWNING EX-OFFICIO DIRECTOR 1.00 55.00 X 0 1303467 255516 RICHARD C SHADYAC JR CEO & EX-OFFICIO DIRECTOR 55.00 1.00 X X 945764 0 123064 EMILY S GREER CHIEF ADMIN. OFFICER 55.00 0.00 X 599371 0 93914 ANURAG PANDIT CHIEF INVESTMENT OFFICER 55.00 0.00 X 578242 0 87864 EMILY CALLAHAN CHIEF MARKETING & EXPERIENCE OFFICER 55.00 0.00 X 557276 0 100518 ROBERT MACHEN CHIEF OPERATING OFFICER (THRU 10/20) 55.00 0.00 X 557020 0 88430 SARA HALL CHIEF LEGAL OFFICER 55.00 0.00 X 513534 0 89864 GEORGE SHADROUI CHIEF STRATEGY OFFICER 55.00 0.00 X 517761 0 79880 ABED ABDO CHIEF FINANCIAL OFFICER 55.00 0.00 X 468112 0 24755 JEFFREY T PEARSON FORMER CHIEF FINANCIAL OFFICER 0.00 0.00 X 350388 0 101133 JOYCE ABOUSSIE VOTING DIRECTOR 4.00 4.00 X 0 0 0 SUSAN MACK AQUILLARD MD VOTING DIRECTOR 4.00 8.00 X 0 0 0 PAUL J AYOUB ESQ VOTING DIRECTOR 4.00 8.00 X 0 0 0 JOSEPH S AYOUB JR ESQ VOTING DIRECTOR 4.00 4.00 X 0 0 0 FREDERICK M AZAR MD VOTING DIRECTOR 4.00 4.00 X 0 0 0 JAMES B BARKATE VOTING DIRECTOR 4.00 4.00 X 0 0 0 MARTHA PERINE BEARD VOTING DIRECTOR 8.00 4.00 X 0 0 0 SHERYL BOURISK VOTING DIRECTOR 4.00 4.00 X 0 0 0 ROBERT A BREIT MD VOTING DIRECTOR 4.00 4.00 X 0 0 0 TERRY L BURMAN VOTING DIRECTOR 4.00 8.00 X 0 0 0 ANN M DANNER VOTING DIRECTOR 4.00 4.00 X 0 0 0 JOSEPH M DEVIVO VOTING DIRECTOR 4.00 4.00 X 0 0 0 FRED P GATTAS III PHARMD VOTING DIRECTOR 4.00 4.00 X 0 0 0 RUTH GAVIRIA VOTING DIRECTOR 4.00 4.00 X 0 0 0 CHRISTOPHER GEORGE MD VOTING DIRECTOR 4.00 4.00 X 0 0 0 JUDY HABIB VOTING DIRECTOR 8.00 4.00 X 0 0 0 GABRIEL HADDAD MD VOTING DIRECTOR 4.00 4.00 X 0 0 0 CHUCK HAJJAR VOTING DIRECTOR 4.00 4.00 X 0 0 0 FOUAD HAJJAR MD VOTING DIRECTOR 4.00 4.00 X 0 0 0 PAUL K HAJAR VOTING DIRECTOR 4.00 4.00 X 0 0 0 FREDERICK R HARRIS JR MD VOTING DIRECTOR 4.00 4.00 X 0 0 0 BRUCE B HOPKINS VOTING DIRECTOR 4.00 4.00 X 0 0 0 J DAVID KARAM II VOTING DIRECTOR 4.00 4.00 X 0 0 0 SHARON L MCCOLLAM VOTING DIRECTOR 4.00 4.00 X 0 0 0 MICHAEL D MCCOY VOTING DIRECTOR 4.00 4.00 X 0 0 0 ROBERT T MOLINET ESQ VOTING DIRECTOR 4.00 4.00 X 0 0 0 RAMZI NUWAYHID VOTING DIRECTOR 4.00 4.00 X 0 0 0 THOMAS PENN III VOTING DIRECTOR 4.00 4.00 X 0 0 0 CHRISTINA M RASHID VOTING DIRECTOR 4.00 4.00 X 0 0 0 CAMILLE F SARROUF JR ESQ VOTING DIRECTOR 4.00 4.00 X 0 0 0 JOSEPH C SHAKER VOTING DIRECTOR 4.00 4.00 X 0 0 0 JOSEPH G SHAKER VOTING DIRECTOR 4.00 4.00 X 0 0 0 MICHAEL SIMON VOTING DIRECTOR 4.00 4.00 X 0 0 0 GEORGE A SIMON II VOTING DIRECTOR 4.00 4.00 X 0 0 0 TONY THOMAS VOTING DIRECTOR 4.00 4.00 X 0 0 0 RICHARD M UNES VOTING DIRECTOR 4.00 4.00 X 0 0 0 PAUL H WEIN ESQ VOTING DIRECTOR 4.00 4.00 X 0 0 0 SUSAN R WINDHAM-BANNISTER VOTING DIRECTOR 4.00 4.00 X 0 0 0 TAMA ZAYDON VOTING DIRECTOR 8.00 4.00 X 0 0 0 5087468 1303467 1044938 469 1 1 0 INFOCISION MANAGEMENT CORPORATION 325 SPRINGSIDE DRIVE AKRON OH 443334501 CALL CENTER 6805127 INNERWORKINGS INC 600 W CHICAGO AVENUE CHICAGO IL 60654 PRINT MATERIALS PRODUCTION 5992418 EAGLECOM INC 2300 YONGE STREET SUITE 1700 TORONTO ONTARIO CA MEDIA PURCHASING 5592972 INFOGROUP INC PO BOX 3243 OMAHA NE 68102 MARKETING & DATA 3596189 VACO MEMPHIS LLC 5410 MARYLAND WAY 460 BRENTWOOD TN 37027 IT CONTRACT LABOR 3481543 172 3355764 8045778 2013028875 47873760 2024430417 33208256 -4526950 37735206 10000 0 10000 10000 10000 1222361741 244975 914663952 210376 307697789 34599 307732388 307732388 8965021 8045778 1390252 7574769 7574769 41488785 12634568 28854217 28854217 3668807 1776750 1892057 1892057 2403702104 28854217 -2634893 353052363 X 997103326 997103326 1632667 332316 506464 793887 142571484 29151784 44194801 69224899 9973212 2019462 2867924 5085826 17967050 3487316 5814872 8664862 9598676 1969875 2833686 4795115 2277599 350756 866762 1060081 374146 374146 11304762 11304762 16859787 3566480 4051086 9242221 441847 66437 307008 68402 30854058 5226294 21147605 4480159 8227250 1442284 2407996 4376970 559277 101610 118800 338867 1008711 180588 407074 421049 35624864 5637030 25493054 4494780 2672708 456224 1162794 1053690 CAMPAIGN EXPENSES 174374721 75085783 15797068 83491870 MAILINGS & SHIPPING 108180581 37283494 16185821 54711266 PRINTING & PUBLICATIONS 6224324 1064492 907335 4252497 TELECOMMUNICATIONS 4683661 1757290 1706101 1220270 40530002 6841832 13586459 20101711 1623044713 1173124673 160736856 289183184 X 146899955 78205212 16382495 52312248 361191285 264937049 50438828 64503789 471608 250298 3791040 4235105 5915751 3357014 371003087 152699797 229260406 218303290 5197268777 7608494510 5848337695 8164081055 55234475 73893594 56690255 50719764 111924730 124613358 X 4667610950 6683886334 1068802015 1355581363 5736412965 8039467697 5848337695 8164081055 780657391 1522397341 0 X 0 1 X 1 0 X 1314189700 1446493050 1667190856 1744366291 2024430417 8196670314 1314189700 1446493050 1667190856 1744366291 2024430417 8196670314 8196670314 23051442 26152721 35719999 25296657 33208256 143429075 719985 754615 0 0 0 1474600 44211185 51485671 55697649 46576106 50453806 248424417 8589998406 0.95420 0.95160 X PART II, LINE 10: COLUMN (A): 2016 - TOTAL OF 44,211,185 CONSISTS OF: A. GROSS FUNDRAISING EVENTS RECEIPTS (LESS CONTRIBUTIONS): 17,139,341 B. GROSS GAMING RECEIPTS: 27,071,844 COLUMN (B): 2017 - TOTAL OF 51,485,671 CONSISTS OF: A. GROSS FUNDRAISING EVENTS RECEIPTS (LESS CONTRIBUTIONS): 19,414,166 B. GROSS GAMING RECEIPTS: 32,071,505 COLUMN (C): 2018 - TOTAL OF 55,697,649 CONSISTS OF: A. GROSS FUNDRAISING EVENTS RECEIPTS (LESS CONTRIBUTIONS): 18,639,338 B. GROSS GAMING RECEIPTS: 37,058,311 COLUMN (D): 2019 - TOTAL OF 46,576,106 CONSISTS OF: A. GROSS FUNDRAISING EVENTS RECEIPTS (LESS CONTRIBUTIONS): 9,405,383 B. GROSS GAMING RECEIPTS: 37,170,723 COLUMN (E): 2020 - TOTAL OF 50,453,806 CONSISTS OF: A. GROSS FUNDRAISING EVENTS RECEIPTS (LESS CONTRIBUTIONS): 8,965,021 B. GROSS GAMING RECEIPTS: 41,488,785 1033682990 7863768 357550674 69170089 1329927343 1055350944 5491426 34726892 61886272 1033682990 1024698330 4864242 64664085 38875713 1055350944 965253422 21281957 92690065 54527114 1024698330 873056599 12552432 103475245 23830854 965253422 0.07500 0.92500 1 0 46179491 46179491 149526361 36122770 113403591 4958222 2623532 2334690 63142487 38552264 24590223 107196526 75401231 31795295 218303290 GLOBAL EQUITY 2659746455 F MARKETABLE ALTERNATIVES 2161686808 F REAL ASSETS 288505103 F PRIVATE EQUITY 1724161730 F FIXED INCOME 604472281 F CASH EQUIVALENTS 169922133 F 7608494510 ANNUITY OBLIGATIONS 50719764 50719764 X 3938734013 1522397341 1522397341 2416336672 -12634568 -12634568 2403702104 1635679281 12634568 12634568 1623044713 0 1623044713 PART V, LINE 4: THE INTENDED USE OF THE ORGANIZATION'S RESERVE FUND IS TO SUPPORT THE CURRENT AND FUTURE NEEDS OF ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. THE FUND HELPS ENSURE THAT ST. JUDE CAN CONTINUE ITS COMMITMENT TO TREATING PATIENTS AND ADVANCING LONG-TERM RESEARCH PROJECTS IN THE YEARS AHEAD - NO MATTER WHAT HAPPENS IN THE ECONOMY OR IN THE EVENT OF A DISASTER. TREATMENTS FOR PEDIATRIC CANCER CAN LAST UP TO 3 YEARS AND COST AN AVERAGE OF $425,000 (AND COULD EXCEED $1 MILLION) PER PATIENT. YET REGARDLESS OF COST, FAMILIES NEVER RECEIVE A BILL FROM ST. JUDE FOR TREATMENT, TRAVEL, HOUSING OR FOOD - SO THEY CAN FOCUS ON HELPING THEIR CHILD LIVE. IN ADDITION, CARE DOESN'T END WHEN TREATMENT IS FINISHED - ST. JUDE FOLLOWS PATIENTS FOR LIFE, LEARNING FROM YESTERDAY'S PATIENTS TO IMPROVE CARE AND OUTCOMES FOR TOMORROW'S CHILDREN. THE RESERVE FUND HELPS ENSURE THAT ST. JUDE CAN FULFILL THAT COMMITMENT TO EACH AND EVERY PATIENT, NOW AND INTO THE FUTURE, REGARDLESS OF THE COST OR DURATION OF THEIR CARE. THE RESERVE FUND ALSO PROVIDES CONFIDENCE FOR ST. JUDE TO LAUNCH AN HISTORIC 6-YEAR, $11.5 BILLION STRATEGIC PLAN - IN THE MIDST OF A GLOBAL PANDEMIC - THAT WILL EXPAND PATIENT SERVICES AND ACCELERATE RESEARCH IN THE U.S. AND GLOBALLY FOR CHILDREN WITH CATASTROPHIC DISEASES. ST. JUDE ALSO HAS ANNOUNCED A NEW SIX-YEAR, ADDITIONAL $200 MILLION PARTNERSHIP WITH THE WORLD HEALTH ORGANIZATION (WHO) TO PROVIDE QUALITY CANCER MEDICINES FOR CHILDREN IN LOW- AND MIDDLE-INCOME COUNTRIES - THE LARGEST FINANCIAL COMMITMENT EVER MADE FOR A GLOBAL EFFORT IN PEDIATRIC CANCER MEDICATIONS, AND THE FUND HELPS ST. JUDE TO LAUNCH MULTIPLE LONG-TERM RESEARCH STUDIES, WITH ASSURANCE OF FUNDING TO SEE THEM THROUGH COMPLETION. CURING CATASTROPHIC DISEASES IN CHILDREN IS A MULTI-TRILLION-DOLLAR, MULTI-YEAR GLOBAL PROBLEM AND ST. JUDE MUST CONTINUE OUR WORK NO MATTER WHAT HAPPENS WITH THE ECONOMY, THE MARKET, FUNDRAISING OR IN THE EVENT OF A DISASTER. PART X, LINE 2: AS OF JUNE 30, 2021, ALSAC HAD NOT IDENTIFIED ANY UNCERTAIN TAX POSITIONS UNDER ASC TOPIC 740, INCOME TAXES, REQUIRING ADJUSTMENTS TO ITS FINANCIAL STATEMENTS. IN THE EVENT ALSAC WERE TO RECOGNIZE INTEREST AND PENALTIES RELATED TO UNCERTAIN TAX POSITIONS, IT WOULD BE RECOGNIZED IN THE FINANCIAL STATEMENTS AS A GENERAL EXPENSE. GENERALLY, TAX YEARS ENDING 2018 THROUGH 2021 ARE OPEN TO EXAMINATION BY THE FEDERAL AND STATE TAXING AUTHORITIES, RESPECTIVELY. THERE ARE NO INCOME TAX EXAMINATIONS CURRENTLY IN PROCESS. PART XI, LINE 4B - OTHER ADJUSTMENTS: DIRECT GAMING EXPENSES -12,634,568. PART XII, LINE 2D - OTHER ADJUSTMENTS: DIRECT GAMING EXPENSES 12,634,568. DIRECT GAMING EXPENSES INDENTIFIED ABOVE REFER TO THE ST. JUDE DREAM HOME GIVEAWAYS. CENTRAL AMERICA AND THE CARIBBEAN INVESTMENTS 2480295593 EUROPE (INCLUDING ICELAND & GREENLAND) INVESTMENTS 118484313 EAST ASIA AND THE PACIFIC INVESTMENTS 43785975 NORTH AMERICA INVESTMENTS 13559736 SOUTH ASIA INVESTMENTS 4970918 SOUTH AMERICA INVESTMENTS 3147230 SUB-SAHARAN AFRICA INVESTMENTS 2434486 CENTRAL AMERICA AND THE CARIBBEAN 0 0 PROGRAM SERVICES EDUCATION AND TRAINING 41224 SOUTH AMERICA 0 0 PROGRAM SERVICES EDUCATION AND TRAINING 20000 RUSSIA AND NEIGHBORING STATES 0 0 PROGRAM SERVICES EDUCATION AND TRAINING 20000 EAST ASIA AND THE PACIFIC 0 0 PROGRAM SERVICES EDUCATION AND TRAINING 20000 SOUTH ASIA 0 0 PROGRAM SERVICES EDUCATION AND TRAINING 20000 0 0 0 0 0 0 2666719475 80000 2666799475 1 0 1 1 1 0 PART III ACCOUNTING METHOD: PART I, LINE 3: EXPENDITURES ARE RECORDED ON AN ACCRUAL BASIS. X X X X X X 1 INFOCISION MANAGEMENT CORP 325 SPRINGSIDE DR AKRON OH 443334501 FUNDRAISING SOLICITOR 0 4822025 4725871 96154 COMMSENSE MONTANA INDUSTRIAL PARK ROAD 459 K AGUADILLA RQ 00603 FUNDRAISING SOLICITOR 0 498856 391134 107722 EAGLECOM INC 2300 YONGE STREET SUITE 1700 BOX TORONTO CA M4P 1E4 FUNDRAISING COUNSEL 0 0 5984306 -5984306 NNE MARKETING LLC 1666 MASSACHUSETTS AVE SUITE 14 LEXINGTON MA 02420 FUNDRAISING COUNSEL 0 0 120000 -120000 ELEVENTY MARKETING GROUP 453 S HIGH ST SUITE 101 AKRON OH 44311 FUNDRAISING COUNSEL 0 0 83451 -83451 5320881 11304762 -5983881 AK AL AR CA CO CT DC FL GA HI IL KS KY LA MA MD ME MI MN MO MS NC ND NH NJ NM NV NY OH OK OR PA RI SC TN UT VA WA WI WV GALA 1062191 566687 495504 36270 10209 GALA 683507 655477 28030 151 15265101 6823614 8441487 180097 108686 33449 364422 657119 17010799 8045778 8965021 180097 108686 33449 400692 667328 1390252 7574769 41488785 7405582 48289 5180697 0 41488785 7405582 48289 5180697 12634568 28854217 CA CO GA ID IL KS KY LA MO MS MT NC NM NV OH OK TN TX VA 0 IN COLORADO, ALSAC CONTRACTS WITH A THIRD PARTY WHO IS LICENSED TO CONDUCT GAMING IN THAT STATE. SEE RESPONSE TO SCHEDULE G, PART III, LINES 15A - C. LICENSES ARE NOT REQUIRED FOR THE GAMING ACTIVITY CONDUCTED BY ALSAC IN THE FOLLOWING STATES LISTED ON LINE 9 ABOVE: MO, MS, MT, NC, OH, OK AND TX. 0 1 0 0.05000 0.95000 KERA WRIGHT 501 ST JUDE PLACE MEMPHIS TN 38105 1 2376244 0 EPSILON SIGMA ALPHA CHAPTER OF COLORADO 363 WEST DRAKE ROAD FORT COLLINS CO 80526 BRIAN DOYLE 172106 MANAGES THE PLANNING AND EXECUTION OVERSIGHT OF RAFFLE ACTIVITIES X 1 10566175 SCHEDULE G, PART III, COLUMN (C), OTHER GAMING: THE ST. JUDE DREAM HOME CAMPAIGN IS A NATIONWIDE PROGRAM TO FURTHER ALSAC'S MISSION BY BUILDING AWARENESS OF THE PROGRAMS AND SERVICES THAT ST. JUDE CHILDREN'S RESEARCH HOSPITAL PROVIDES, SPECIFICALLY, WITH RESPECT TO ITS ROLE IN LEADING THE WAY THE WORLD UNDERSTANDS, TREATS AND DEFEATS CHILDHOOD CANCER AND OTHER LIFE-THREATENING CHILDHOOD DISEASES. IN CONNECTION WITH THE OPPORTUNITY TO PURCHASE A RAFFLE TICKET FOR THE OPPORTUNITY TO WIN A HOME, THE ST. JUDE DREAM HOME CAMPAIGN PROVIDES NATIONAL REACH AND MARKETING EXPOSURE FOR ALSAC'S MISSION TO SUPPORT THE MISSION OF ST. JUDE. OVER 5.8 MILLION WEBSITE PAGE VIEWS, AN ESTIMATED 22,000 TV AND RADIO PLACEMENTS, OVER 5.8 MILLION PIECES OF DIRECT MAIL, PRESENCE IN 44 MARKETS NATIONWIDE IN 19 SEPARATE STATES, OVER 23 MILLION SOCIAL MEDIA IMPRESSIONS, 1.8 MILLION EMAILS DEPLOYED AND AN ESTIMATED 600 PLUS BROADCAST NEWS STORIES TO SPREAD INFORMATION ABOUT THE MISSION OF ST. JUDE ARE JUST A FEW OF THE RESULTS ACHIEVED BY THIS CAMPAIGN. ALTHOUGH NATIONAL IN SCOPE, THE CAMPAIGN IS DIRECTED TO SPECIFIC, TARGETED MARKETS WHERE A MARKETING OUTREACH CAMPAIGN CAN RESULT IN STRONG AWARENESS FOR THE MISSION OF ST. JUDE. THE EXTENSIVE AND INTENSIVE COMMUNITY ENGAGEMENT SURROUNDING THE ST. JUDE DREAM HOME EVENTS IS DESIGNED TO ENGAGE THE PUBLIC IN THE AWARENESS CAMPAIGN ABOUT ST. JUDE, EXPOSING LARGE NUMBERS IN THE COMMUNITY TO THE ALSAC/ST. JUDE MISSION REGARDLESS OF WHETHER AN INDIVIDUAL PURCHASES A RAFFLE TICKET. THE MARKETING EFFORTS ASSOCIATED WITH THE ST. JUDE DREAM HOME CAMPAIGN CONTRIBUTE IMPORTANTLY TO RAISING THE AWARENESS NECESSARY TO INCREASING COMMUNITY ENGAGEMENT WITH ST. JUDE CHILDREN'S RESEARCH HOSPITAL (INCLUDING TAKING ADVANTAGE OF THE IMPORTANT SERVICES ST. JUDE PROVIDES), AS WELL AS TO ATTRACT AND RETAIN NEW DONORS TO ENSURE THE CONTINUED OPERATION OF ST. JUDE NOW AND IN THE FUTURE, WHILE ALSO ENSURING THAT NO FAMILY EVER RECEIVES A BILL FROM ST. JUDE FOR TREATMENT, TRAVEL, HOUSING OR FOOD. THE ST. JUDE DREAM HOME CAMPAIGN, THROUGH THE TELEVISION AND RADIO PROGRAMS, PLACEMENTS, FUNDRAISING AND PUBLIC AWARENESS EVENTS, ALSO BENEFITS OUR EDUCATION, TRAINING AND COMMUNITY SERVICE PROGRAM OBJECTIVES THAT SUPPORT THE ST. JUDE MISSION AND ABILITY TO CONTINUE TO LEAD THE WAY THE WORLD UNDERSTANDS, TREATS AND DEFEATS CHILDHOOD CANCER AND OTHER LIFE-THREATENING DISEASES. PART III, LINE 17B, MANDATORY DISTRIBUTIONS BY STATE: CA - $3,424,410 ID - $1,284,430 IL - $623,653 KY - $1,044,000 LA - $1,599,114 NV - $1,114,765 TN - $1,159,722 VA - $316,081 1 ST JUDE CHILDREN'S RESEARCH HOSPITAL INC 262 DANNY THOMAS PLACE MEMPHIS TN 38105 620646012 501(C)(3) 997103326 SUPPORT FOR OPERATIONAL AND CAPITAL BUDGET NEEDS 1 0 PART I, LINE 2: THE SOLE RECIPIENT OF GRANTS AND SUPPORT IS ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. ALSAC IS THE FUNDRAISING AND AWARENESS ORGANIZATION FOR ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. ALSAC EXISTS SOLELY TO RAISE FUNDS AND BUILD AWARENESS TO SUSTAIN THE MISSION OF ST. JUDE. X 1 1 X X X X X X 1 1 0 0 0 0 0 0 0 JAMES R DOWNING EX-OFFICIO DIRECTOR 0 1194386 0 100150 0 8931 0 230350 0 25166 0 1558983 0 0 RICHARD C SHADYAC JR CEO & EX-OFFICIO DIRECTOR 877077 0 0 0 68687 0 103459 0 19605 0 1068828 0 64529 0 EMILY S GREER CHIEF ADMIN. OFFICER 540552 0 0 0 58819 0 74309 0 19605 0 693285 0 56229 0 ANURAG PANDIT CHIEF INVESTMENT OFFICER 552352 0 0 0 25890 0 66460 0 21404 0 666106 0 21732 0 EMILY CALLAHAN CHIEF MARKETING & EXPERIENCE OFFICER 526180 0 0 0 31096 0 75763 0 24755 0 657794 0 30466 0 ROBERT MACHEN CHIEF OPERATING OFFICER (THRU 10/20) 473128 0 0 0 83892 0 67483 0 20947 0 645450 0 11523 0 SARA HALL CHIEF LEGAL OFFICER 480277 0 0 0 33257 0 70086 0 19778 0 603398 0 31808 0 GEORGE SHADROUI CHIEF STRATEGY OFFICER 475586 0 0 0 42175 0 68896 0 10984 0 597641 0 38017 0 ABED ABDO CHIEF FINANCIAL OFFICER 467188 0 0 0 924 0 0 0 24755 0 492867 0 0 0 JEFFREY T PEARSON FORMER CHIEF FINANCIAL OFFICER 122413 0 0 0 227975 0 98124 0 3009 0 451521 0 8028 0 PART I, LINE 1A HEALTH OR SOCIAL CLUB DUES: A SOCIAL CLUB MEMBERSHIP WAS MADE AVAILABLE TO THE CEO BUT LIMITED TO BUSINESS PURPOSES IN ACCORDANCE WITH A WRITTEN POLICY DIRECTIVE. THE AMOUNT OF THE MEMBERSHIP WAS NOT TREATED AS TAXABLE INCOME BECAUSE THE USE WAS BUSINESS RELATED. PART I, LINE 4A: UNDER A VOLUNTARY SEPARATION AGREEMENT ENTERED INTO BY THE EMPLOYEE AND THE ORGANIZATION, THE EMPLOYEE IS ENTITLED TO SEVERANCE PAY. THE TERMS AND CONDITIONS TO RECEIVE SEVERANCE PAYMENTS ARE CONFIDENTIAL. ALL SEVERANCE AGREEMENTS, WHEN LEGALLY PERMITTED, INCLUDE A RELEASE OF CLAIMS. SEVERANCE PAYMENTS WERE MADE DURING THE YEAR TO THE FOLLOWING LISTED PERSONS IN PART VII: ROBERT MACHEN $71,238 JEFFREY T. PEARSON $219,590 PART I ,LINE 4B: THE ORGANIZATION ESTABLISHED A NON-QUALIFIED DEFERRED COMPENSATION PLAN PURSUANT TO CODE SECTION 457(F) OF THE INTERNAL REVENUE CODE. THE PLAN AMOUNTS ARE SUBJECT TO SUBSTANTIAL FUTURE SERVICE REQUIREMENTS TO THE ORGANIZATION AND ARE SUBJECT TO SUBSTANTIAL RISK OF FORFEITURE. NONQUALIFIED PLAN PAYMENTS WERE MADE DURING THE YEAR TO THE FOLLOWING LISTED PERSONS IN PART VII: RICHARD C. SHADYAC, JR. $64,529 EMILY S. GREER $56,229 ANURAG PANDIT $21,732 EMILY CALLAHAN $30,466 ROBERT MACHEN $11,523 SARA HALL $31,808 GEORGE SHADROUI $38,017 JEFFREY T. PEARSON $8,028 CARTER HOPKINS SEE PART V 73755 EMPLOYMENT 0 COURY SHADYAC SEE PART V 209255 EMPLOYMENT 0 KARON NASH SEE PART V 80850 EMPLOYMENT 0 SCHEDULE L, PART IV, BUSINESS TRANSACTIONS INVOLVING INTERESTED PERSONS: (A) NAME OF INTERESTED PERSON: CARTER HOPKINS(B) RELATIONSHIP BETWEEN INTERESTED PERSON AND ORGANIZATION: FAMILY MEMBER OF VOTING DIRECTOR, BRUCE B. HOPKINS(C) AMOUNT OF TRANSACTION: $73,755(D) DESCRIPTION OF TRANSACTION: EMPLOYMENT(E) SHARING OF ORGANIZATION REVENUES? = NO SCHEDULE L, PART IV, BUSINESS TRANSACTIONS INVOLVING INTERESTED PERSONS: (A) NAME OF INTERESTED PERSON: COURY SHADYAC(B) RELATIONSHIP BETWEEN INTERESTED PERSON AND ORGANIZATION: FAMILY MEMBER OF OFFICER (CEO & EX-OFFICIO DIRECTOR), RICHARD C. SHADYAC, JR.(C) AMOUNT OF TRANSACTION: $209,255(D) DESCRIPTION OF TRANSACTION: EMPLOYMENT(E) SHARING OF ORGANIZATION REVENUES? = NO SCHEDULE L, PART IV, BUSINESS TRANSACTIONS INVOLVING INTERESTED PERSONS: (A) NAME OF INTERESTED PERSON: KARON NASH(B) RELATIONSHIP BETWEEN INTERESTED PERSON AND ORGANIZATION: FAMILY MEMBER OF OFFICER (CHIEF ADMIN. OFFICER), EMILY S. GREER(C) AMOUNT OF TRANSACTION: $80,850(D) DESCRIPTION OF TRANSACTION: EMPLOYMENT(E) SHARING OF ORGANIZATION REVENUES? = NO X 59 X 19 X 3 X 2780 47830339 COST OR SELLING PRICE X 24 X 53 X DIGITAL ASSETS 4 43421 COST OR SELLING PRIC X PRIZE PACKAGES 193 0 X GIFT CARDS 67 0 X OTHER PRIZES 149 0 3 0 1 1 PART I, COLUMN (B): THE NUMBERS IN COLUMN (B) REFER TO A COMBINATION OF THE NUMBER OF CONTRIBUTIONS AND THE NUMBER OF ITEMS RECEIVED. PART I, LINE 32B: ALSAC PARTNERED WITH CHARITABLE ADULT RIDES (CARS) FOR SALE OF VEHICLES DONATED TO THE ORGANIZATION. CARS WORKS WITH VENDORS THROUGHOUT THE COUNTRY TO PICK-UP DONATED VEHICLES AND SELL THE VEHICLE. ALSAC ALSO PARTNERED WITH CARS TO ALLOW SUPPORTERS TO DONATE VEHICLES DIRECTLY TO CARS WITH THE PROCEEDS FROM THE SALE BENEFITING THE ORGANIZATION. PART I, LINE 33: RECEIPTS FOR LINES 1,6,7,15,18,25,26 AND 27 ARE REPORTED ON THE FORM 990, PART VIII, LINE 8A OR LINE 9A. FORM 990, PART III, LINE 4A: CURING CATASTROPHIC DISEASES IN CHILDREN IS A MULTI-TRILLION-DOLLAR, MULTI-YEAR GLOBAL PROBLEM AND ALSAC AND ST. JUDE MUST CONTINUE OUR WORK NO MATTER WHAT HAPPENS WITH THE ECONOMY, THE MARKET, FUNDRAISING OR IN THE EVENT OF A DISASTER. ST. JUDE IS A RESEARCH HOSPITAL, SO NONE OF THE CUTTING-EDGE RESEARCH COSTS AND MANY OF THE EXTENSIVE TREATMENTS AND SERVICES WE PROVIDE ARE NOT COVERED BY INSURANCE, AND MAY NOT BE IN THE FUTURE. UNLIKE OTHER HOSPITALS THAT RECEIVE 90-95% OPERATING REVENUES FROM INSURANCE RECOVERIES AND PATIENT COPAYS, THE MAJORITY OF OUR FUNDING COMES FROM GENEROUS DONORS AND INVESTMENT INCOME TO SUPPORT NEEDS NOW AND IN THE FUTURE. IN THE YEARS AHEAD, AN ESTIMATED 87% OF THE FUNDS NECESSARY TO RUN ST. JUDE MUST BE RAISED BY ALSAC FROM GENEROUS DONORS. WHEN ST. JUDE OPENED ITS DOORS IN 1962, THE SURVIVAL RATE FOR CHILDHOOD CANCER WAS 20%. SINCE THAT TIME, TREATMENTS INVENTED AT ST. JUDE HAVE HELPED PUSH THE OVERALL SURVIVAL RATE FOR CHILDHOOD CANCER TO MORE THAN 80% TODAY. ST. JUDE WON'T STOP UNTIL NO CHILD DIES FROM CANCER. TODAY, ST. JUDE IS LEADING THE WAY THE WORLD UNDERSTANDS, TREATS, AND DEFEATS CHILDHOOD CANCER AND OTHER LIFE-THREATENING DISEASES. ST. JUDE IS THE FIRST AND ONLY NATIONAL CANCER INSTITUTE-DESIGNATED COMPREHENSIVE CANCER CENTER DEVOTED SOLELY TO CHILDREN. ST. JUDE IS ALSO THE FIRST WORLD HEALTH ORGANIZATION (WHO) COLLABORATING CENTRE FOR CHILDHOOD CANCER. THIS YEAR, IN PARTNERSHIP WITH THE WHO, ST. JUDE ANNOUNCED A NEW SIX-YEAR, ADDITIONAL $200 MILLION INITIATIVE TO PROVIDE QUALITY CANCER MEDICINES FOR CHILDREN IN LOW- AND MIDDLE-INCOME COUNTRIES. THIS REPRESENTS THE LARGEST FINANCIAL COMMITMENT EVER MADE FOR A GLOBAL EFFORT IN CHILDHOOD CANCER MEDICINES. RECENTLY, ST. JUDE ANNOUNCED A SIGNIFICANT ADVANCEMENT IN OUTCOMES FOR CHILDREN WITH HIGH-RISK NEUROBLASTOMA. THIS NEW THERAPY, DEVELOPED AT ST. JUDE, DELIVERS AN INCREASE IN SURVIVAL RATES OF MORE THAN 20 PERCENTAGE POINTS, TO 74 PERCENT. PRIOR TO THIS BREAKTHROUGH, THE SURVIVAL RATE HAD REMAINED AT APPROXIMATELY 51 PERCENT FOR A DECADE. ST. JUDE SHARES THE BREAKTHROUGHS IT MAKES, AND EVERY CHILD SAVED AT ST. JUDE MEANS DOCTORS AND SCIENTISTS WORLDWIDE CAN USE THAT KNOWLEDGE TO SAVE THOUSANDS MORE CHILDREN. IN ADDITION TO CHILDHOOD CANCER, ST. JUDE PLAYS A CRITICAL LEADERSHIP ROLE IN GROUNDBREAKING STUDIES ON SICKLE CELL DISEASE, INFECTIOUS DISEASES, AND GENETIC DISORDERS. THESE EFFORTS ARE INSTRUMENTAL TO IMPROVING CARE FOR CHILDREN AROUND THE WORLD. A ST. JUDE PATIENT WAS THE FIRST IN THE WORLD TO BE CURED OF SICKLE CELL DISEASE WITH A BONE MARROW TRANSPLANT, AND ST. JUDE HAS ONE OF THE LARGEST PEDIATRIC SICKLE CELL PROGRAMS IN THE COUNTRY. AND ST. JUDE'S EFFORTS DON'T END WHEN TREATMENT STOPS. THE ST. JUDE AFTER COMPLETION OF THERAPY (ACT) PROGRAM IS THE LARGEST LONG-TERM FOLLOW-UP CLINIC FOR PEDIATRIC CANCER PATIENTS IN THE UNITED STATES AND ST. JUDE DOES THIS AT NO COST TO THE PATIENTS. THE CLINIC HELPS PATIENTS STAY HEALTHY AFTER ACTIVE TREATMENT ENDS AND HAS BEEN A PROTOTYPE FOR OTHER LONGER TERM FOLLOW-UP PROGRAMS. FORMER ST. JUDE PATIENTS ALSO ARE PARTICIPATING IN THE ST. JUDE LIFE STUDY, DESIGNED TO HELP ADULT SURVIVORS OF CHILDHOOD CANCER LEARN ABOUT ISSUES THAT AFFECT THEIR HEALTH AS WELL AS WAYS TO STAY HEALTHY. ST. JUDE IS ALSO HOME TO THE CHILDHOOD CANCER SURVIVOR STUDY, A COLLABORATIVE STUDY AMONG U.S. AND CANADIAN INSTITUTIONS THAT INCLUDES MORE THAN 20,000 CHILDHOOD CANCER SURVIVORS WITH THE AIM TO IMPROVE SURVIVORSHIP OUTCOME AND QUALITY OF LIFE. IN ADDITION, BRAIN TUMOR SCIENCE AND TECHNOLOGY AT ST. JUDE ARE AT THE CUTTING EDGE WORLDWIDE, AND ST. JUDE HAS THE LARGEST RESEARCH-BASED PEDIATRIC BRAIN TUMOR PROGRAM IN THE COUNTRY. ST. JUDE IS THE COORDINATING CENTER OF THE NATIONAL PEDIATRIC BRAIN TUMOR CONSORTIUM, WHICH RECEIVES FUNDING FROM THE NATIONAL CANCER INSTITUTE. ST. JUDE'S COMMITMENT TO ADVANCING THE FRONTIERS OF RESEARCH ARE EVIDENT IN THE OPENING OF THE NEW, $412M INSPIRATION4 ADVANCED RESEARCH CENTER (I4ARC), WHICH OFFERS SPACE FOR COMPUTATIONAL BIOLOGY, ARTIFICIAL INTELLIGENCE AND ONE OF THE MOST ADVANCED MICROSCOPES IN THE WORLD. IN ADDITION, THE I4ARC HOUSES LABS FOR IMMUNOLOGY, DEVELOPMENTAL NEUROBIOLOGY AND CELLULAR AND MOLECULAR BIOLOGY. THE CENTER CREATES AN INVITING SPACE FOR CLINICIANS, PHYSICIANS AND RESEARCH FROM ACROSS MULTIPLE DISCIPLINES TO COLLABORATE. FORM 990, PART V, LINE 4B (CONTINUED): THE FINANCIAL ACCOUNTS IN THE FOREIGN COUNTRIES LISTED ON FORM 990, PART V, LINE 4B (AND SCHEDULE O) ARE RELATED TO INVESTMENTS. NO FINANCIAL ACCOUNTS FOR OPERATIONAL PURPOSES WERE MAINTAINED IN FOREIGN COUNTRIES. FORM 990, PART VI, SECTION A, LINE 2 FAMILY RELATIONSHIP AMONG DIRECTORS: JOSEPH S. AYOUB, JR., ESQ. AND PAUL J. AYOUB, ESQ.; ROBERT A. BREIT, MD AND JOSEPH G. SHAKER; JOSEPH C. SHAKER AND JOSEPH G. SHAKER. FORM 990, PART VI, SECTION B, LINE 11B EACH YEAR, THE AUDIT AND COMPLIANCE COMMITTEE AND OFFICERS OF THE BOARD ARE PROVIDED WITH A DRAFT COPY OF THE FORM 990 AND ALL REQUIRED SCHEDULES. THE AUDIT AND COMPLIANCE COMMITTEE MEETS WITH ITS TAX PREPARER TO REVIEW THE DRAFT FORM 990 BEFORE IT IS FILED WITH THE IRS. ADDITIONALLY THE COMPENSATION COMMITTEE OF THE BOARD IS PROVIDED WITH A DRAFT COPY OF THE COMPENSATION SECTIONS OF THE FORM 990, AND THE CONFLICT OF INTEREST COMMITTEE OF THE BOARD IS PROVIDED WITH A DRAFT COPY OF THE CONFLICT-OF-INTEREST SECTIONS OF THE FORM 990 FOR REVIEW BEFORE THE FINALIZED DOCUMENT IS FILED WITH THE IRS. EACH VOTING MEMBER OF THE BOARD IS PROVIDED WITH A FINAL COPY OF THE FORM 990 AND ALL REQUIRED SCHEDULES BEFORE IT IS FILED WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C THE ORGANIZATION MAINTAINS A CONFLICT OF INTEREST COMMITTEE OF THE BOARD OF DIRECTORS. IN ADDITION TO EDUCATION OF NEW BOARD MEMBERS ON THE CONFLICT OF INTEREST POLICY, THE ADMINISTRATOR TO THE BOARD/CHIEF GOVERNANCE OFFICER MONITORS CONFLICT MANAGEMENT PLANS (WHICH MAY INCLUDE CHANGING VENDORS, DIVESTITURE OF FINANCIAL INTERESTS, AND THE LIKE) TO ENSURE THEY ARE COMPLETED IN A TIMELY FASHION. UNDISCLOSED CONFLICTS ARE DISCOVERED, WHERE POSSIBLE, THROUGH THE ORGANIZATION'S CONTRACTING PROCESS. THIS IS TRUE FOR THE BOARD'S CONFLICT OF INTEREST POLICY AND FOR THE SEPARATE CONFLICT OF INTEREST POLICY APPLICABLE TO ALL ADMINISTRATION OF THE ORGANIZATION (POTENTIAL CONFLICTS OF THE ORGANIZATION ARE DISCUSSED AND RESOLVED AT A SENIOR-LEVEL CONFLICTS OF INTEREST COMMITTEE). POTENTIAL RESTRICTIONS RANGE FROM UNWINDING OR PROHIBITING A TRANSACTION, TO PREVENTING SOMEONE FROM PARTICIPATING IN A DELIBERATION, TO SIMPLE DISCLOSURE TO THE BOARD OF THE CONFLICTING INTEREST, DEPENDING ON THE FACTS AND CIRCUMSTANCES OF THE CONFLICT. FORM 990, PART VI, SECTION B, LINE 15 AN INDEPENDENT COMPENSATION COMMITTEE OF THE BOARD, ADVISED BY AN INDEPENDENT OUTSIDE EXPERT, ANNUALLY REVIEWS THE REASONABLENESS OF THE TOTAL REMUNERATION PAID TO THE CEO, OTHER OFFICERS, AND CERTAIN OTHER EMPLOYEES. THE LAST REVIEW WAS COMPLETED IN DECEMBER 2021. THE BOARD'S EXECUTIVE TOTAL COMPENSATION PHILOSOPHY IS INTENDED TO SUPPORT THE ORGANIZATION'S OVERALL STRATEGY AND OBJECTIVES, ATTRACT AND RETAIN EMPLOYEES, LINK COMPENSATION TO PERFORMANCE AND THE ATTAINMENT OF THE ORGANIZATION'S OBJECTIVES, AND PROVIDE COMPENSATION AT A REASONABLE COST WHILE FULFILLING THE CHARITABLE MISSION OF THE ORGANIZATION. THE BOARD TARGETS TOTAL REMUNERATION BETWEEN THE 50TH AND 75TH PERCENTILES OF THE DEFINED COMPARATOR MARKET, WHILE GIVING DUE CONSIDERATION TO THE MISSION AND THE CHARITABLE NATURE OF THE ORGANIZATION. NO REVIEWED EMPLOYEE'S TOTAL REMUNERATION WAS OVER THE 75TH PERCENTILE FOR THE REPORTING YEAR. FORM 990, PART VI, SECTION C, LINE 19 GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART IX, LINE 26: WE CONDUCT A NUMBER OF ACTIVITIES, WHICH JOINTLY BENEFIT OUR EDUCATION, TRAINING, AND COMMUNITY SERVICE PROGRAM OBJECTIVES, AS WELL AS FUNDRAISING AND GENERAL AND ADMINISTRATIVE ACTIVITIES. THE EDUCATIONAL INFORMATION SHARED WITHIN THESE ACTIVITIES SUPPORT OUR MISSION TO LEAD THE WAY THE WORLD UNDERSTANDS, TREATS AND DEFEATS CHILDHOOD CANCER AND OTHER LIFE-THREATING DISEASES AND INCLUDE OUR TELEVISION AND RADIO PROGRAMS AND PLACEMENTS, DIRECT MAIL PROGRAM, AND CERTAIN OTHER FUNDRAISING AND PUBLIC AWARENESS EVENTS. IN ACCORDANCE WITH THE FINANCIAL ACCOUNTING STANDARDS BOARD GUIDELINES, WE ALLOCATED A PORTION OF OUR FUNDRAISING EXPENSES TO PROGRAM SERVICE AND GENERAL AND ADMINISTRATIVE EXPENSES IN OUR COMBINED STATEMENTS OF FUNCTIONAL EXPENSES. ST JUDE CHILDREN'S RESEARCH HOSPITAL INC 262 DANNY THOMAS PLACE MEMPHIS TN 38105 620646012 HOSPITAL TN 501(C)(3) 3 N/A 0 TESTAMENTARY TRUSTS WITH VESTED RESIDUAL OR PERPETUAL INTERESTS (21) FIDUCIARY TN N/A T 1 0 1 1 0 0 0 0 0 0 1 0 1 0 1 0 1 1 0 0 VARIOUS TESTAMENTARY TRUSTS C 11780272 CASH OR CASH EQUIVALENT DIST. SCHEDULE R, PART IV: THE RELATED ENTITIES REPORTED ARE TESTAMENTARY TRUSTS IN WHICH ALSAC HAS A GREATER THAN 50% BENEFICIAL INTEREST. THE EIN AND STATE OF LEGAL DOMICILE VARY BY TRUST.